Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy
The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
The bisphosphonates 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid (ABP), 3-amino-1, 1-hydroxypropane-1, 1-diphosphonic acid (APD), and 1-hyroxyethane-1, 1-diphosphonic acid (EHDP) were compared for their ability to inhibit the osteoclastic resorption of bone in culture. This was achieved by measuring the effect of bisphosphonate concentration on the number of resorption pits formed and the total area of resorption. During this analysis, a new application of reflected polarized light microscopy was developed that has advantages over other microscopy techniques, including scanning electron microscopy (SEM), as applied to the analysis of resorbed bone surfaces. Based on area analysis, the bisphosphonates were effective for the range 10−7–10−8 M, with ABP about two to five times more effective than EHDP or APD. Similar data were obtained by counting the number of resorption pits but with EC50 10 times higher. At lower concentrations (10−9 M), bisphosphonates may enhance the formation of resorption pits. APD was found to be more toxic (10 times) than ABP or EHDP to osteoclasts and mononuclear cells, but toxic concentrations were at least 102 times higher than the resorption EC50. These data plus immunofluorescence, SEM, and transient incubation experiments show that it is the bisphosphonate-bone complex that directly inhibits the excavation of resorption pits by mature osteoclasts. The mechanism of action does not appear to require inhibition of osteoclast differentiation or toxic elimination of osteoclasts. Bisphosphonates, however, subtly affect the cytoskeleton of osteoclasts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bisphosphonates do not appear to suppress osteoclastogenesis (129, 140, 141)”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [129]
In the citing paper
“In contrast, bisphosphonates have a different mechanism of action that can be associated with normal or even increased osteoclast numbers despite clear antiresorptive effects (129 -138).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [129]
Citations
Cites
Izzard, C. S., & Lochner, L. R. (1976) · Journal of Cell Science · doi:10.1242/jcs.21.1.129 · Cited by 705
Seaweeds and ulcerative colitis in laboratory animals.
Marcus, R., & Watt, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90187-1 · Cited by 427
Resorption of bone by isolated rabbit osteoclasts
Chambers, T. J., Revell, P. A., Fuller, K., & Athanasou, N. A. (1984) · Journal of Cell Science · doi:10.1242/jcs.66.1.383 · Cited by 413
Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
Boonekamp, P. M., van der Wee-Pals, L. J. A., LENNEP, M. V., Cw, T., & Bijvoet, O. L. (1986) · PubMed · Cited by 345
Inoué, S. (1986) · Springer eBooks · doi:10.1007/978-1-4757-6925-8 · Cited by 342
Schenk, R., Eggli, P., Fleisch, H., & Rosini, S. (1986) · Calcified Tissue International · doi:10.1007/bf02555748 · Cited by 315
Structure-activity relationships of various bisphosphonates
Shinoda, H., Adamek, G., Felix, R., Fleisch, H., Schenk, R., & Hagan, P. (1983) · Calcified Tissue International · doi:10.1007/bf02405012 · Cited by 306
TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)
Frijlink, W. B., Bijvoet, O. M., Te Velde, J., & Heynen, G. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91318-7 · Cited by 258
Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.
Elomaa, I., Blomqvist, C., Gröhn, P., Porkka, L., Kairento, A.-L., Selander, K., Lamberg-Allardt, C., & Holmström, T. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92755-1 · Cited by 209
Quantitative reflection contrast microscopy of living cells.
Bereiter-Hahn, J., Fox, C. H., & Thorell, B. (1979) · The Journal of cell biology · doi:10.1083/jcb.82.3.767 · Cited by 195
Flanagan, A. M., & Chambers, T. J. (1989) · Bone and Mineral · doi:10.1016/0169-6009(89)90021-4 · Cited by 195
Dr. Löwik, C. W. G. M., Van Der Pluijm, G., Van Der Wee-Pals, L. J. A., Van Treslong-De Groot, H. B., & Bijvoet, O. L. M. (1988) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650030210 · Cited by 191
Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple Myeloma
Siris, E. S., Sherman, W. H., Baquiran, D. C., Schlatterer, J. P., Osserman, E. F., & Canfield, R. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198002073020602 · Cited by 185
ARNETT, T. R., & DEMPSTER, D. W. (1987) · Endocrinology · doi:10.1210/endo-120-2-602 · Cited by 181
EFFECTS OF DISODIUM DICHLOROMETHYLENE DIPHOSPHONATE ON PAGET'S DISEASE OF BONE
Meunier, P. J., Alexandre, C., Edouard, C. M., Mathieu, L., Chapuy, M. C., Bressot, C., Vignon, E. P., & Trechsel, U. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91551-4 · Cited by 154
Bisphosphonates--history and experimental basis.
Fleisch, H. (1987) · PubMed · Cited by 151
Comparison of two parenteral diphosphonates in hypercalcemia of malignancy
Jung, A. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90813-0 · Cited by 120
Practical electron microscopy for biologists
Pettitt, J. M. (1970) · Micron (1969) · doi:10.1016/0047-7206(70)90034-8 · Cited by 116
Françon, M. (1961) · Pergamon Press eBooks · doi:10.5962/bhl.title.5902 · Cited by 113
Miller, S. C., & Jee, W. S. S. (1979) · The Anatomical Record · doi:10.1002/ar.1091930309 · Cited by 112
METHODS FOR THE EARLY RECOGNITION OF COR PULMONALE
JONES, E. S., Scarrow, G. D., Sechiari, G., & Roberts, D. V. (1964) · The Lancet · doi:10.1016/s0140-6736(64)92229-9 · Cited by 101
Boonekamp, P. M., Löwik, C. W. G. M., van der Wee-Pals, L. J. A., Ml, V. W.-V. L., & Bijvoet, O. L. (1987) · PubMed · Cited by 100
Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients.
Minaire, P., Berard, E., Meunier, P. J., Edouard, C., Goedert, G., & Pilonchery, G. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110331 · Cited by 96
The alteration of osteoclast morphology by diphosphonates in bone organ culture
Rowe, D. J., & Hausmann, E. (1976) · Calcified Tissue International · doi:10.1007/bf02546397 · Cited by 74
Influence of a diphosphonate on the cellular aspect of young bone tissue
Plasmans, C. M. T., Jap, P. H. K., Kuijpers, W., Slooff, T. J. J. H., & Wijers, M. (1980) · Calcified Tissue International · doi:10.1007/bf02408548 · Cited by 72
Lerner, U. H., & Larsson, Å. (1987) · Bone · doi:10.1016/8756-3282(87)90018-4 · Cited by 47
Optical and scanning electron microscopy in the single osteoclast resorption assay.
BOYDE, A., Ali, N. N., & Jones, S. J. (1985) · PubMed · Cited by 45
Computer-aided surface reconstruction of interference contours
Cline, H. E., Holik, A. S., & Lorensen, W. E. (1982) · Applied Optics · doi:10.1364/ao.21.004481 · Cited by 44
Attardo-Parrinello, G. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090105018 · Cited by 44
Variation in the sizes of resorption lacunae made in vitro.
Jones, S. J., BOYDE, A., Ali, N. N., & Maconnachie, E. (1986) · PubMed · Cited by 26
Francisx, M. D., & Slough, C. L. (1984) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600730818 · Cited by 21
Optical and Scanning Electron Microscopy in the Single Osteoclast Resorption Assay
BOYDE, A., Ali, N. N., & Jones, S. J. (1985) · Digital Commons - USU (Utah State University) · Cited by 19
Sato, M., & Rodan, G. A. (1989) · Elsevier eBooks · doi:10.1016/b978-0-12-664655-9.50014-2 · Cited by 14
Self-citationWink, C. S. (1986) · Cells Tissues Organs · doi:10.1159/000146187 · Cited by 12
Cited by
Marx, R. E. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(03)00720-1 · Cited by 3,036
Bisphosphonates: The first 40years
Russell, R. G. G. (2011) · Bone · doi:10.1016/j.bone.2011.04.022 · Cited by 1,124
“This is much higher than the concentrations of bisphosphonates required to affect osteoclast morphology and cause osteoclast apoptosis in vitro [130].”
BackgroundBisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,040
Bisphosphonates: Mechanisms of Action
Fleisch, H. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0325 · Cited by 1,019
Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115539 · Cited by 1,004
“5 mM(data not shown), the EC50 for osteoclast 24-h cytotoxicity (42).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Sato, M., & Grasser, W.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Sato, Masahiko
- ORCID
- Sato, Masahiko
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-01-01
- Volume
- 5
- Issue
- 1
- Pages
- 31-40
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1974903174
- Cited by
- 264
- References
- 35
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 5 · 2015: 5 · 2014: 6 · 2013: 1 · 2012: 6
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Merck Sharp and Dohme
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- bisphosphonates, osteoclasts, bone resorption, 1-hydroxyethane-1,1-diphosphonic acid, resorption pits, bisphosphonate toxicity, mechanism of action
- MeSH terms
- Pamidronate, Animals, Bone Resorption, Cattle, Cell Survival, Diphosphonates, Microscopy, Fluorescence, Microscopy, Phase-Contrast, Microscopy, Polarization, Osteoclasts, Rats, Inbred Strains, Etidronic Acid, Video Recording, Alendronate, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.